angiotensin ii has been researched along with syringin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, F; Tang, Q; Wu, Q; Yang, Z; Yuan, Y; Zhang, N; Zhou, M; Zhu, J | 1 |
1 other study(ies) available for angiotensin ii and syringin
| Article | Year |
|---|---|
Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cell Line; Glucosides; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phenylpropionates; Pressure; Rats; Signal Transduction | 2017 |